Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecemotide with ADT and Radiation in Prostate Cancer
NCT01496131Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Oct 2011
- Primary completion
- Nov 2016
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of tecemotide in prostate cancer (PCa), sponsored by EMD Serono. Started Oct 2011; status: completed.
02
Drugs
tecemotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01496131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01496131.